Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PTMDP (Post-translational Modification Derived Products) as Markers of Frailty in Elderly Subjects

NCT02816580 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT02816580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PTMDP (Post-translational Modification Derived Products) as Markers of Frailty in Elderly Subjects
Lead sponsor
CHU de Reims
Phase
Not applicable
Overall status
Completed
Start date
February 23, 2015
Completion date
October 2, 2019
Enrollment
254 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly persons